| Home | E-Submission | Sitemap | Contact Us |  
top_img
Cancer Research and Treatment > Accepted Articles
doi: https://doi.org/10.4143/crt.2023.981    [Accepted]
Predicted Cervical Cancer Prevention: Impact of National HPV Vaccination Program on Young Women in South Korea
Kyeongmin Kwak1,2 , Seung-sik Hwang3
1Department of Occupational and Environmental Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea
2Department of Environmental and Occupational Health, Korea University Graduate School of Public Health, Seoul, Korea
3Department of Public Health Sciences, Seoul National University Graduate School of Public Health, Seoul, Korea
Correspondence  Seung-sik Hwang ,Tel: 82-2-880-2715, Fax: 82-2-762-2888, Email: cyberdoc@snu.ac.kr
Received: August 29, 2023;  Accepted: January 11, 2024.  Published online: January 15, 2024.
ABSTRACT
Purpose
This study aimed to evaluate the effectiveness of the National HPV Vaccination Program of South Korea among its entire female population, particularly among younger age groups.
Materials and Methods
We first predicted the incidence of cervical cancer over the next 20 years (2021–2040) using the Nordpred package based on Møller’s age–period–cohort model under several scenarios for the National HPV Vaccination Program. We calculated the potential impact fractions (PIFs) and proportional differences under the current national vaccination programs, and alternative scenarios using the no-vaccination assumption as a reference.
Results
We estimated that the current national vaccination program would prevent 4.13% of cervical cancer cases and reduce the age-standardized incidence rate (ASR) by 8.79% in the overall population by 2036–2040. Under the alternative scenario of implementing the nine-valent vaccine, 5.13% of cervical cancer cases could be prevented and the ASR reduced by 10.93% during the same period. In another scenario, expanding the vaccination age to 9-17 years could prevent 10.19% of cervical cancer cases, with the ASR reduced by 18.57% during the same period. When restricted to ages <40 years, the prevention effect was remarkably greater. We predict that the current national HPV program will reduce its incidence by more than 30% between 2036 and 2040 in women aged <40 years.
Conclusion
The effectiveness of the vaccination program in reducing the incidence of cervical cancer was confirmed, with a considerable impact anticipated in younger age groups.
Key words: Uterine Cervical Neoplasms, Papillomavirus Vaccines, Human Papillomavirus Viruses, Potential Impact Fraction
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Share:      
METRICS
0
Crossref
0
Scopus
494
View
40
Download
Related article
Results of Colorectal Cancer Screening of the National Cancer Screening Program in Korea, 2008  2010 December;42(4)
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI